In the original article, there were several errors in “Figures and Figure legends.”
In Figure 2 as published, the letters B and C which indicated the figure order were marked in reverse. In Figure 4, the letters from B to E which indicated the figure order were marked in reverse, and the figure label “EGF” was missed in the second and third bands in western blots in Figure 4B. In Figure 6B, the figure label “EGFR” was marked as “β-actin” mistakenly. Besides, we mistakenly wrote PD-L1 as DKK1 in Figure legends 2, 4, and 6 because of our carelessness. The corrected Figures 2, 4 and 6 appear below.
FIGURE 2
FIGURE 4
FIGURE 6
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Wang X, Liang C, Yao X, Yang R-H, Zhang Z-S, Liu F-Y, Li W-Q, Pei S-H, Ma J, Xie S-Q and Fang D (2021) Corrigendum: PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC. Front. Pharmacol. 12:724799. doi: 10.3389/fphar.2021.724799
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.